Magenta Therapeutics Inc (NASDAQ:MGTA)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - MGTA

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - MGTA

  • Market Cap$328.120m
  • SymbolNASDAQ:MGTA
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS55910K1088

Company Profile

Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to extend the curative power of stem cell transplant, gene therapy, genome editing and cell therapy. The pipeline of the company includes C100, C200, C300, MGTA-145, MGTA-156, E478 and G100.Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to bring the curative power of bone marrow transplant.

Latest MGTA news

Currently there for this company. Visit our news hub for other news .